CA

Tim G Elford

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kronos Bio, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tim G Elford. Retrieved from https://idiyas.com/inventor/tim-g-elford-xs3egtvm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tim G Elford: Innovator in Pharmaceutical Chemistry

Introduction

Tim G Elford is a notable inventor based in California, recognized for his contributions to pharmaceutical chemistry. He has made significant strides in the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Tim G Elford holds a patent for "Hydrates of polymorphs of 6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)-2,3-dihydroimidazo[1,2-a]pyrazin-8-amine bis-mesylate as Syk inhibitors." This patent details the polymorphs of a bis-mesylate salt of a compound of Formula IA. It also includes processes for making the polymorphs and methods of use thereof. He has 1 patent to his name.

Career Highlights

Tim is currently employed at Kronos Bio, Inc., where he continues to advance his research in the field of drug development. His work focuses on creating innovative solutions that address unmet medical needs.

Collaborations

Throughout his career, Tim has collaborated with esteemed colleagues, including Peter Chee-Chu Fung and Jesper Alexis Jernelius. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Tim G Elford is a prominent figure in the realm of pharmaceutical innovation, with a focus on developing new compounds that hold promise for future therapies. His contributions to the field are noteworthy and continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…